AOA Dx YC Demo Day Pitch (S21) - Blood Test for Early Detection of Ovarian Cancer
AOA Dx is developing the next frontier in early-stage cancer detection for women through our pioneering work in glycolipids and proprietary biomarker technology.
Other contents